MedPath

Study of the Depth of Anesthesia on Postoperative Clinical Outcome in Patients With Supratentorial Tumor

Not Applicable
Completed
Conditions
Anesthesia, Brain Tumor, Supratentorial,Outcome
Interventions
Other: Bispectral index will be targeted at 35
Other: Bispectral index will be targeted at 50
Registration Number
NCT03033693
Lead Sponsor
Beijing Tiantan Hospital
Brief Summary

Recent studies have shown that deep anesthesia is associated with poor outcome. There is still lack of randomized controlled trials with large sample size on the effect of depth of anesthesia on the postoperative outcomes in patients undergoing brain tumor resection. The investigators are performing a randomized and parallel group trial. The aim of the study is to determine whether there is a causal relationship between the depth of anesthesia and postoperative clinical outcome in patients undergoing supratentorial tumor surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1461
Inclusion Criteria
  • Patients scheduled to receive elective supratentorial tumor resection under general anesthesia from 2017 to 2019 will be recruited in the trial. Inclusion criteria include ages between 18 and 80 years old, American Society of Anesthesiologists (ASA) physical status Ⅲ-Ⅳ, surgery duration expected to be equal or more than three hours, postoperative hospital stay expected to be equal or more than five nights, and monitoring BIS throughout anesthesia.
Exclusion Criteria
  • Patients who undergo emergency or awake craniotomy surgery, or unable to present the written consent will be excluded from the trial. The patients whose incision site conflicts with the placement of BIS electrode on the frontal and temporal lobe will also be excluded from the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
The deep anesthesia groupBispectral index will be targeted at 35-
The light anesthesia groupBispectral index will be targeted at 50-
Primary Outcome Measures
NameTimeMethod
Disability-free survival ratePostoperative 30 days

World Health Organization Disability Assessment Schedule 2.0 Scale will be used to assess the body disability. Disability is defined as a 4-point increasement in the WHODAS score.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Beijing Tian Tan Hospital

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath